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Background. The infl uence of low doses of aflatoxin 8} (A FBI ) Will partial hepatectomy
(PH) on 8Iuhtrllion~·S· tr'lII.if(·rase (CST) acrh'iry wns SfUdieci in rl lt' p las ma llIld U\'cr Uf l 'H~
rat. Methods. The animals were divided into fou groups. The firs ! (/J and the second ( /I)
group were treated with AFBr freshly dissolved in dimethyl sulphoxide (DMSO). and ad-
ministered as a single intraperitoneal dose of50 jlg/ral 24 hrs after the rats had undergone
either shom operation or. 40% PH respecti vdy. 711t' third group (Ill) of animals was
treated with a total dose of I mg AFBr -5 days per week during a period of 8 weeks. TI,e
non-treated animals were used as controls (e). Result s. We observed a significant increase
of CST activity in the plasma of all experimental groups compared 10 the controls (C).
(1'<0.02101'<0.005). In the liver. the CST activity ofall experimental groups was also sig-
nificantly increased. compared 10the controls (from 1'<0.02 10 p<0.OO5). Conclusion. TI,e
administration of both single and multiple (loses ojAFBI Jed to long term increase of CST
activity in ti ll' rat plasma and liver, and partial hepatectomy had 110 significant effect 01 1
this phenomenon.
Key wor d s: utlutoxlns: ra rcino~ens; glutat hione transfcruse; liver-;
plasm a ; ra ts.
Introduction
Aflatoxins are widely distributed in the nature and the
most important of these closely related mycotoxins is afla-
toxin BI (AFBd , which is a metabolite of certain Aspergil -
lus species (A. flavus and A. parasiticus} . These arc wide-
spread fungi, which can conta minate animal and human
fooO (1). It is known that AFB I is hepatotoxic and hepato-
carcinogenic in many anima l species. including rats (2. 3),
and also humans (4). The liver is an important target of the
toxicity of drugs . xenobiotics and oxidative stress (5). Many
chemica l compounds are modified by liver extracts to yield
active compounds (among these arc epoxides), and their ac-
tions arc usually directed to macromolecules such as DNA
(6, 7). In order to exen its biological effects (acute toxicity,
reratogenecity, mutagenicity and carcinogenicity) , AFB I
must be convened to its reactive cpcxlde (Figure 1) by cy-
tochrome P450 enzyme system of liver and several other
tissues of different animal s (8. 9). The epoxide is highly re-
active, and can form derivatives with several cellular mac-
romolecules. including DNA. RNA. and proteins. It is be-
lieved that covalent interaction of epoxide with DNA is re-
sponsible for the initiation of carcinogenesis followed by
the subsequent step of promotion and progression. and that
it leads to cancer formation (7) .
Hepatic antioxidants represent the major defence
against toxic liver injury. and they act J.O;; anrl-apopronc
agents (10).
With respect to the capacity for AFB, oxidat ion, srnk-
ing differences exis t among microsomes prepared from dif-
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In our experiments we observed a significant increase
of GST activity in the plasma of all three experimental
groups compared to controls. as presented in Figure2.
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further analysis. All chemicals were the
products of Sigma (St. Louis. MO. USA).
Fresh blood was immediately collected us-
ing heparin (1000 Ulml) as anticoagulant.
Aliquots of blood were taken immediately
after exsanguinations and centrifuged for
the separation of plasma. For the determi-
nation of GST activity in the plasma and
liver l-chloro-z.a-dinitrobenzene (CDNB)
was used as a substrate (17). Protein content
was determined by the method of Lowry et
al. using bovine serum albumin as a referent value (18).
The obtained data were statistically analyzed and ex-
pressed as mean values ± SE. and differences between the
experimental and the control group were estimated by Stu-
dent's r-tcst (19). The value of p<O.05 was considered sta-
tistically significant.
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FiJ.:. I - Conversion of aflatoxin B I to aflatoxin8 1 - 8.9 epoxide in the liver
fcrent species. Human liver microsomes are approximately
one-fourth as efficient in activating AFB, as rat micro-
somes. For many years it has been perceivedthat the mouse
and rat. though closely related. respond in a completely dif-
ferent way to hepatocarcinogenic effects of aflatoxin HI
(I I). Mouse microsomes have higher specific activity for
AFBl-8.9-epoxide (AFBO) production than rat rnlcrosomes.
but arc resistant to the hcpa tocarcincgcnic effects of AFB,
because of the efficient conj ugation of AFBO with gluta thi-
one (GS H) (12. 13). Glutathione-Svtransferase (GST) is in-
volved in detoxification of epoxides through conjugation
between GSH and AFB, ( 14). GST is found in cy tosol of
cells in vertebrates, plants. insects. nematodes. yeasts. and
aerobic bacteri a. In mammalian organisms GST is present in
all tissues. hut the highest activity of this enzyme was found
in the liver. representing up to 10%of total protein amount.
GST activity might be a key factor in determining in-
dividual or species susceptibility to AFBIo and the major
route of detoxification of AFB1 via conjugation of AFBO
withGSH is in rodents. noticeably.
Satoh et of. showed that hepatectomy enhanced tumor
development in rats given chemical carcinogencs ( 15).
The aim of this study was to investigate the influence
of low doses of AFB, and partia l hepatectomy (PH) on GST
activity in the plasmaand liver of the rats.
Crpana 416
Methods
Male rats of the inbred Albino Oxford (AO) strain
(~-6 weeks old) were used in (he experiment. Animals were
kept in wire-bottomed cages under the standardized condi-
lions of humidity. light and temperature at the Institute for
Medical Research of the Military Medical Academy. Food
and water weregiven at/libitum.
The animals were divided into four groups. The first
(I) and the second (II) group were treated with AFB, freshly
dissolved in dimethyl sulphoxidc (DMSO). administered as
a single intraperitoneal dose of 50 ug/ru t (24 hrs after the
rats underwent a shamoperation. or 40% PH. respectively).
The third gro up (III) of rats was treated with a total dose of
I mg AFB1 • 5 days per week during 8 weeks. Non treated
animals were used as the controls (C).
Partial hepatectomy was performed according to the
technique of Higgins and Anderson (16). The animals were
sacrificed 13-1 5 months after the administration of AFn l .
The livers were excissed within 3 minutes and prepared for
Flg. 2 - Changes of gfuunhionc-Suransferusc (GST)
activity in the plasma of rats sacrificed 13-15 months after
AFB. treatment.
AFB, was administered intrapcritoneally to nus in the single dose of 50
IltUral 24 brs afterthe rats underwent 3 sham operation (I) or..w%
Q3nial hepatectomy (II) and in multiple doses 5 day!iJwcck. (lotal doses
of 1 mg AFB, in 8 weeks) (III). Norureared animal s represcmed
controls(C). The number of animals is gi·..en in parentheses.
The sham operated rats 2.. hrs before the treatment
with AFB1 showed lower than 2-fold increase in GST activ-
ity. compared to the control value (p<O.02). The most sig-
nificanl increase (near 2-fold. p<O.OO5) was in the group of
rats II which underwent hepatectomy 24 hrs before the sin-
gle treatment with AFBI.Thc highest increase in GST activ-
ity in plasma was detected in the group of rats III, which
were treated for two months with I mg of AFB I .IS a tota l
dose (2.5- fold. p<O.OI).
Changesof GST activity in the liver of the ruts treated
by APB1 are presented in Figure 3A and 30. A significant
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increase (p<O.O I) of specific activity of aST from gro up II
was found in comparison to the control animals (Figure
3A). \Vhen the activity of GST was expressed in gram of
the wet mass of tissue (Figure 3B) the values were more
significant in all three experimental groups of animals in rc-
spcc t to the co ntrol rats (p<O.O I and 1'<0.(05).
Fig. 3 - Changes of glutarhlonc -Saransferase (GSn activity in
the liver of rats after AFBl lrea lmcnl
ArB l was admin istered.Intropcritoncnlly to the rats in the single dose of
50 ~glral 24 hrs after the rats underwent a sham ope ration (I). or 40%
partial hepa tectomy ( II), and in multiple doses 5 days/week (total doses
of I mg AFBI in 8 weeks) (III) . Nomreared anima ls represented
controls (C). The number of anima ls is given in parentheses.
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(22) . Many of the ear lier studies showed that multiple dose s
of AFB. led to the deve lopment of liver tumors in rats be-
tween the l st and the 2nd yea r afte r poisoning (23) . Other
studies showed that PH co mbined with AFB . enhanced tu-
mor development (20) .
An importa nt de toxi fication pathway in anima ls - the
conjugation of AFB, 10 aSH (mediated by aST) and its
subsequent excretion is related to AFB. toxici ty resistencc
(24). Differences in AFB. susceptibility of various species
depended on their hepatic cytosol capability to inactivate
AFBO by conjugation with aSH (25. 26). Mice occured
highly resistant to the hepa tocarci nogenic effects of afla-
toxin (27) . Although mouse microsomes produced relative ly
more AFB O than rat microsomes under similar incubation
cond itions. mice were more resistant to the hepatocarcino-
ge nic effects of AFB) beca use of the efficie nt co njugation of
AF BO with GSH (28) . Liver cytosolic fracti ons from the
mouse had 50- to 100- fold greater AFBO conjugating ac-
tivity than those from the rat (12 ).
Individuals with high activity of oxidative enzymes
and/or low activity of detoxifying enzymes might be at the
increased risk for certa in types of cancers. For AFB, cancer
risk estimation. the rates of cy tochrome P450 (CY P).
mediated AFB, activation. as wcll as a ST-catalyzed AFBO
-de toxifica tion must be co ncide red (29) .
Slone et al. (28) analyzed hepatic cytosol lc fractio ns
prepared from 14 huma n donors for GST act ivity . Human
liver cyrosolic GST exhibited low activity towards AFRO
(0. 17·1.46IlmoVminlmg). Hepatic aST·AFBO activities of
the rat. hamster and mouse were 70-, 465-. and 3545·fold
grea ter. respec tively. than the ones observed in human liver
using microsomally-generated AFBO.
In our experiment. total hepatic GST activities towards
AFBO measured one yea r afte r ArB. poisoning. were in-
creased 10-40%, co mpared to the co ntrols.
Earlier studies ( 15) with purified GST from the rat liver
indicated different activity of certain class of this enzy me to-
wards AFBO. In the direct contrast to a large number of other
drug -metabo lizing enzymes. aST·p (subunit of neutral aST
purified from placenta) was found not to be inducible in the
livers of rats by short-term administration of drugs or car-
cinogens such as phenobarbital. a butylated hydroxyanisole.
N·2· lIuorenylacclamide . 3-methylcholanthrenc . 3'methyI4-
d imcthylaminoazobcnzene. However, two chemica l carcino-
gens diethylnitrosarninc, and N·2- fluorenylacetamidc. plus
partial hepatectomy induced prencoplastic foci and hyper-
plastic nodules in rat liver and elevated the amounts of GST-P
30-50 limes. compared 10 normal liver (15). On the basis of
their results, Satoh et of. concluded that GST-P might be ex-
peered to have a crucial role in relation to the resistance
mechani sm or, more directly, to the growth of preneoplastic
cells.
Liu et 01. (30) found pers istent express ion of aST-p in
all the livers of AFB I -treatcd rats during three time inter-
vals (I. 3, and 12 months) after AF B. poiso ning. Since there
were no liver tumors induced within one year after AFB,
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Different studies in rats have demonstrated the potent
toxic and carcinogenic effects of aflatoxins (2) . Despite the
differences. (differe nt sources of aflatoxin - food con tami-
nated with AFB 1 or purifi ed AFB!> different routes of ad-
ministration. different periods of adminis tration and obscr-
Val ion. different basic diets and different strains of rats). all
of these studies found that aflatoxin was a very potent he-
patic carcinogen in rats fed for the period of 20 weeks. or
longer. A few studies found that even sing le. relative ly high
doses were capable of producing hepatocellu lar carcinoma
( 12). The se lected doses of AF B, that were used in our
study were potentially ca ncerogenic (20. 21). Sublethal
doses of aflatoxins led to chronic toxicity that caused can-
cerogenic changes. Lethal dose of AFB I varied and de-
pended on strain difference. animal's age and other factors
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treatment, these data suggested that all AFB I -treatcd ani-
mals were at the prcneoplastic stage of hepatocarcinogene-
sis. The aST-p positive foci thought represented the popu-
lations of the ..initiated" cells with altered gene expression
(15) . AFB, Induction resulted in aST-p overexpression. but
not in the expression of p53 tumor-suppressor gene that
played an important role in hepatocarcinogenesis (30).
These results suggested that the p53 gene mutation might
net have occured at this early stage of AFB, • induced
hepatocarcinogenesis,
In our experiments neoplastic nodules and hepato-
cellular carcinoma were not detected in the group of rats
II which underwent 40 % PH 24 hrs before the single
treatment with AFB1 (results not presented). It occurred.
that the strain difference and the timing of AFB I admini-
stration in relation to PH might have had a critical role in
tumor development (3 1). The experiments in which rats
underwent two thirds PH, and 24 brs later received 0.25
mg/kg body we igh' of AFB,. showed a sig nificant ly
higher incidence of hepatocellu lar carcinoma. com pared
to non-hepa tecto mized rats sacrificed between the 55th
and the 65t h wee k (20). Mortalit y du ring AFB, admi ni-
stra tion was much lower when the rats underwent a one
thi rd hepatectomy (40%), than in the ex periment in whic h
more extensive hepatectomy was performed (70%) (3 1).
In our expe riments the mor tality fro m hepatectomy was
70 % in AFB,- lreated rats.
In almost all the experimental syste ms. multiple dosing
AFB I was required for carci noge nicity (13) . A sing le ad-
ministration of AFB 1 to the rats resulted in maximum liver
AFB1-DNA adduct levels 2 hrs after poisoning. The rapid
remova l of these adducts (88% after 24 hrs) might be re-
lated to the requirement for multip le exposures to AFB I for
the induction of tumors in the fischer rats (21).
The effect of chronic adrni nistnuion of AFO I on GST
(hepatic phase II metabo lizing enzyme) was measured one
year after poison ing in the group III of animals treated with
total dose of I mg AFB,- 5 days/week in the period of 8
weeks. GST activity was significantly increased after multi-
ple doses of AFB,.
Guerre el al. (32) reported a significant decrease in
cytosolic GST in a rabbits sacrificed 2.$ hrs after the last
oral administration (0.10 mg/kg AFB, for 5 days). In rats
GST activity measured with CDNB as a substrate occured
unaffected by such a treatment. suggesting differences in
the rat GST sensitivity to AFB 1 compared to the rabbit
(33) .
A variety of dietary factors have been shown to influ-
ence the carcinogencty of aflatoxin. \Vang et al. (3.$) have
found that crocetin (a natural carotenoid) enhanced GST
activity in rat liver and protected against the AFD I hepato-
toxicity . The incidence of liver lesions in male Wistar rats
treated with AFB, (total dose of 1.125 mg/ral) und crocetin
was sign ificantly reduced (for 40%) in respec t to the ani-
mals treated with AFB 1 alone.
Conclusion
Consistent with the obtained data we concluded that
the administration of both single and mult iple doses of
A FBI led to a long time increase of GST activity in the rat
plasma and liver, and that partial hepatectomy had no sig-
nifican t effec t on this phenomenon.
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PROMENE U AKTIVNOSTI GLUTATION-S-TRANSFERAZE U PLAZMII
JETRI PACOVA INOUKOVANE AFLATOKSINOM B,
uvod. Ispitivan je uticaj niskih doza aflatoksina B, (AFB,) i parcija lne hepatek-
tomije (PH) na aktivnost glutation-S-transferaze (GST) u plazmi i jetri pacova.
Metode. Livotinje su podeljene u celiri grupe. Prva (I) i druga (II) grupa su trel·
rane AFB, prethodno sveze raslvaranim u dimetilsulloksidu (OMSO) i davanim u
jednoj intraperitonealnoj dozi od 50 I1g po pacovu (24 easa posle izvrsene tazne
operacije iii 40% PH). Treca grupa (III) bila je tretirana ukupnom dozom od 1 mg
AFB.. pel puta nedeljno tokom osam nedelja . LivOlinje koje nisu lretirane prEd·
stavljale su kontrolnu grupu (C). Rezultatl . Znacajno povecan]e GST aktivnosli
(1'<0,02 - 1'<0,005) u poredenju sa kontrolnom grupom, utvrdeno je i u plazmi i u
jetri svih ispitivanih grupa pacova. Zakljucak. Oobijeni rezultati pokazuju da jed-
nokratna, kao i visekratna primena niskih doza AFB, dovodi do dugotrajne induk-
cije aktivnosti GST u plazmi i jetri pacova, te da parcijalna hepatektomija nema
vecl uticaj na ovaj lenomen .
Iipoj 4
K I] u C n ere C I : aflatokslnl ; karclnogenl; glutatlon transferaze;
jetra; plazma ; pacovl.
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